Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]

证券代码：688152 证券简称：麒麟信安 公告编号：2025-050 一、获得补助的基本情况 湖南麒麟信安科技股份有限公司（以下简称"公司"）及控股子公司麒麟信安 （广东）科技有限公司于近日收到政府补助款项合计 647.99 万元，属于与收益 相关的政府补助款项。 湖南麒麟信安科技股份有限公司 关于公司及子公司获得政府补助的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 特此公告。 湖南麒麟信安科技股份有限公司 董事会 2025 年 5 月 28 日 二、补助的类型及其对公司的影响 根据《企业会计准则第 16 号-政府补助》的有关规定，公司获得的上述政府 补助属于与收益相关的政府补助。上述政府补助未经审计，具体的会计处理及对 公司 2025 年度损益的影响，最终以审计机构年度审计确认后的结果为准，敬请 投资者注意投资风险。 ...

证券代码：688152 证券简称：麒麟信安 公告编号：2025-049 湖南麒麟信安科技股份有限公司 关于注销部分募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意湖南麒麟信安科技股份有限公司首次 公开发行股票注册的批复》（证监许可【2022】2092 号）核准，湖南麒麟信安 科技股份有限公司（以下简称"麒麟信安"或"公司"）向社会公开发行人民币普通 股（A 股）1,321.1181 万股，发行价格为 68.89 元/股，募集资金总额为人民币 910,118,259.09 元，扣除本次发行费用人民币 76,927,075.33 元（不含税）后，实 际募集资金净额为人民币 833,191,183.76 元。上述募集资金已于 2022 年 10 月 20 日全部到位，天职国际会计师事务所（特殊普通合伙）对本次发行募集资金到账 情况进行了审验，并出具了天职业字[2022]41533 号《验资报告》。 二、募集资金管理情况 公司于 2025 年 2 月 14 ...

麒麟信安公告，公司及控股子公司麒麟信安(广东)科技有限公司近日收到政府补助款项合计647.99万 元，属于与收益相关的政府补助款项。上述政府补助未经审计，具体的会计处理及对公司2025年度损益 的影响，最终以审计机构年度审计确认后的结果为准。 ...

Core Viewpoint - 麒麟信安 has shown significant growth in 2024, with a revenue of 286 million yuan, marking a 75.24% year-on-year increase, and a net profit of 7.94 million yuan, successfully turning a profit [1] Group 1: Financial Performance - In 2024, the company achieved a revenue of 286 million yuan, a 75.24% increase compared to the previous year [1] - The net profit for 2024 was 7.94 million yuan, indicating a successful turnaround from previous losses [1] - The revenue from the power industry reached 139 million yuan, growing by 75.91% year-on-year, accounting for nearly 50% of total revenue [1] Group 2: Business Development - The company’s defense business is expected to accelerate by 2025 after a period of stagnation [1] - The growth in the power sector is attributed to the company's long-term investments and the introduction of new products, including cloud computing and information security solutions [2] - The company is actively expanding into other sectors, with revenue growth outside of power and special industries noted in the previous year [2] Group 3: Future Outlook - The State Grid is projected to invest over 650 billion yuan in 2025, which is expected to increase demand for domestic operating systems, cloud computing, and commercial password products [2] - The company is enhancing its national network layout to better penetrate various sectors, including government, education, healthcare, and transportation [2] - The company plans to launch an intelligent operation system for its cloud platform, integrating AI and machine learning technologies [3]

湖南启元律师事务所 关于湖南麒麟信安科技股份有限公司 湖南启元律师事务所 关于湖南麒麟信安科技股份有限公司 致：湖南麒麟信安科技股份有限公司 湖南启元律师事务所接受湖南麒麟信安科技股份有限公司（以下简称"公司"） 的委托，指派本所律师出席了公司 2024 年年度股东大会（以下简称"本次股东大 会"），对本次股东大会的召集和召开程序、出席会议人员及召集人的资格、表决 程序和表决结果的合法有效性进行现场律师见证，并发表本法律意见。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》 （以下简称"《证券法》"）、 《上市公司股东会规则》 （以下简 称"《股东会规则》"）等法律、法规和规范性文件以及《湖南麒麟信安科技股份 有限公司章程》（以下简称"《公司章程》"）的有关规定，出具本法律意见书。 法律意见书 二零二五年五月 本所律师出具本法律意见书基于公司已作出如下承诺：所有提供给本所律师 的文件的正本以及经本所律师查验与正本保持一致的副本均为真实、完整、准确。 为出具本法律意见书，本所依法审核了公司提供的下列资料： 会 有关的通知等公告事项； 书等； 登记记录及相关资料； 鉴此 ...

二零二五年五月 湖南启元律师事务所 关于湖南麒麟信安科技股份有限公司 2024 年年度股东大会的法律意见书 致：湖南麒麟信安科技股份有限公司 湖南启元律师事务所接受湖南麒麟信安科技股份有限公司（以下简称"公司"） 的委托，指派本所律师出席了公司 2024 年年度股东大会（以下简称"本次股东大 会"），对本次股东大会的召集和召开程序、出席会议人员及召集人的资格、表决 程序和表决结果的合法有效性进行现场律师见证，并发表本法律意见。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简 称"《股东会规则》"）等法律、法规和规范性文件以及《湖南麒麟信安科技股份 有限公司章程》（以下简称"《公司章程》"）的有关规定，出具本法律意见书。 本所律师出具本法律意见书基于公司已作出如下承诺：所有提供给本所律师 的文件的正本以及经本所律师查验与正本保持一致的副本均为真实、完整、准确。 湖南启元律师事务所 关于湖南麒麟信安科技股份有限公司 2024年年度股东大会的 法律意见书 为出具本法律意见书，本所依法审核了公司提供的下列资料： 1、 ...

湖南麒麟信安科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 5 月 21 日 证券代码：688152 证券简称：麒麟信安 公告编号：2025-048 （二） 股东大会召开的地点：湖南省长沙高新开发区麒云路 20 号麒麟科技园 1 栋 1 楼 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 70 | | --- | --- | | 普通股股东人数 | 70 | | 2、出席会议的股东所持有的表决权数量 | 51,767,791 | | 普通股股东所持有表决权数量 | 51,767,791 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 65.7463 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 65.7463 | ...

Group 1 - Vanke A's largest shareholder, Shenzhen Metro Group, plans to provide a loan of up to 1.55 billion yuan to repay the company's bonds [1] - Yidelong reported a net profit of 41.77 million yuan for Q1 2025, a year-on-year increase of 34.19% [1] - Overseas Chinese Town A achieved a contract sales amount of 1.78 billion yuan in April, a year-on-year increase of 10% [1][2] Group 2 - Dajin Heavy Industry's subsidiary signed a contract worth approximately 1 billion yuan for an offshore wind power project with a European energy company [4] - Liao Port Co. announced the resignation of Chairman Wang Zhixian due to reaching retirement age [4] - China Energy Construction's application for a specific stock issuance has been approved by the Shanghai Stock Exchange [6] Group 3 - Xinhua Insurance reported a 27% year-on-year increase in premium income from January to April, totaling 85.38 billion yuan [11] - 吉祥航空's passenger turnover increased by 6.34% in April, with a seat occupancy rate of 86.16% [13] - New City Holdings reported a contract sales amount of approximately 1.76 billion yuan in April, a year-on-year decrease of 52.46% [28] Group 4 - Three Yuan Bio announced a preliminary ruling of a 3.49% countervailing duty on its products in the U.S. [23] - Shanghai Pharmaceutical's product, Wengjing Decoction Granules, has been approved for production [20] - A strategic cooperation agreement was signed between *ST Dali and Zhuhai Yunzhou Intelligent Technology Co., Ltd. to promote the development of intelligent unmanned equipment [22] Group 5 - The construction of the automotive lightweight forging precision processing project by Sanlian Forging has been completed [25] - The company Tianma Technology reported an output of approximately 1,480.16 tons of eel in April [18][19] - The company Victory Technology plans to invest up to 3 billion yuan for share repurchase [42]

证券代码：688152 证券简称：麒麟信安 公告编号：2025-047 湖南麒麟信安科技股份有限公司 关于持股 5%以上股东减持股份计划公告 重要内容提示： 股东持股的基本情况 截至本公告披露日，湖南高新创业投资集团有限公司（以下简称"湖南高新 创投"）持有湖南麒麟信安科技股份有限公司（以下简称"麒麟信安"或"公司"） 股份 4,043,437 股，持股比例 5.14%。上述股份均于 2023 年 10 月 28 日全部解除 限售并上市流通。 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 集中竞价减持计划的主要内容 公司近日收到公司持股 5%以上股东湖南高新创投发来的《关于股份减持计 划的告知函》，因股东自身资金需求，湖南高新创投计划自本公告披露之日起 15 个交易日后的三个月内，即 2025 年 6 月 5 日起至 2025 年 9 月 2 日期间，通过集 中竞价交易的方式减持公司股份合计不超过 787,386.39 股，合计减持比例占公司 总股本的比例不超过 1%。如遇派息、送股、转增股本、配股等除权除息 ...